EPISODE · May 28, 2025 · 9 MIN
2105: Q&A with Poolbeg Pharma CEO, Jeremy Skillington
from The Vox Markets Podcast · host Vox Markets Podcast
Watch on YouTubeFollowing on from its £4.865 million raise last week, Poolbeg #POLB has announced that it has received FDA Orphan Drug Designation for POLB 001. Chief executive Jeremy Skillington joins us to tell us what it all means.
NOW PLAYING
2105: Q&A with Poolbeg Pharma CEO, Jeremy Skillington
0:00
9:05
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of The Vox Markets Podcast?
This episode is 9 minutes long.
When was this The Vox Markets Podcast episode published?
This episode was published on May 28, 2025.
What is this episode about?
Watch on YouTubeFollowing on from its £4.865 million raise last week, Poolbeg #POLB has announced that it has received FDA Orphan Drug Designation for POLB 001. Chief executive Jeremy Skillington joins us to tell us what it all means.
Can I download this The Vox Markets Podcast episode?
Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!